Seurat Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Seurat Therapeutics?

Seurat Therapeutics has 3 investors including National Institute of Neurological Disorders and Stroke And Scott Meadow.

Q: How much funding has Seurat Therapeutics raised to date?

Seurat Therapeutics has raised obfuscated.

Overview

Seurat Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Seurat Therapeutics

CB Rank

87119

A Company providing Safer and more Effective maigraine Medication.

Founded

obfuscation

Private

Grant

Chicago, Illinois, United States

11-50

www.seurat-therapeutics.com/

Pharmaceutical

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Richard Kraig: Co-Founder & CSO
Martin Sanders: Co-Founder & Chairman

Details

Legal Name

Seurat Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Martin Sanders, Richard Kraig, Yuan Zhang

About the Company

Seurat Therapeutics sprung from the University of Chicago and is currently based at the Polsky Exchange. They are a team passionate about innovating migraine care and accelerating the translation of scientific discoveries into life-changing medicine. The science behind Seurat Therapeutics is based on years of research from the University of Chicago

medical center.

Phone Number

(312) 248-2964

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

IGF-1 Nasal Delivery for Migraines

A treatment involving the nasal delivery of insulin-like growth factor-1 (IGF-1) to reduce susceptibility to cortical spreading depression and associated migraine pain.

IGF-1 Nasal Delivery for Chronic Pain

A treatment using nasal delivery of IGF-1 to reduce mechanical pain behavior responses in preclinical models of fibromyalgia and other chronic pain conditions.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Seurat Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institute of Neurological Disorders and Stroke	Yes	Grant - Seurat Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Seurat Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Seurat Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Seurat Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Seurat Therapeutics	—